Todos Med Ltd (TOMDF)

[GreeseMonkey]

RS goal of 1:10 has been discussed many times in presentations, and on Twitter. 1:10 is the company target they believe is achievable when certain catalysts are reached. They intend to have catalysts on both sides of the RS to drive value before and after the uplist.

The 10B shares is to allow Todos to acquire the remaining 48% of 3CL Pharma currently owned by NLC. It wasn't requested for SH vote so the company could go on a dilution trip off the deep end.

Of course, some will have concerns about that. But company has been cash-flow neutral for some time and has only diluted a small amount over the last 6 months to restructure debt. Most of the weekly updates over the last 6 months are zero shares issued. I don't see that changing as revenues continue to grow.